Birth Weight and Polycystic Ovary Syndrome in Adult Life: Is There a Causal Link?

被引:13
|
作者
Paschou, Stavroula A. [1 ]
Ioannidis, Dimitrios [2 ]
Vassilatou, Evangeline [3 ]
Mizamtsidi, Maria [1 ]
Panagou, Maria [2 ]
Lilis, Dimitrios [2 ]
Tzavara, Ioanna [2 ]
Vryonidou, Andromachi [1 ]
机构
[1] Hellen Red Cross Hosp, Dept Endocrinol & Diabet, Athens, Greece
[2] Amalia Fleming Hosp, Dept Endocrinol & Diabet, Athens, Greece
[3] Attikon Univ Hosp, Dept Med 2, Endocrine Unit, Athens, Greece
来源
PLOS ONE | 2015年 / 10卷 / 03期
关键词
PITUITARY-ADRENAL AXIS; CHILDREN BORN SMALL; INSULIN-RESISTANCE; BODY-SIZE; GESTATIONAL-AGE; SEX-HORMONES; WOMEN; HYPERANDROGENISM; ORIGINS; GROWTH;
D O I
10.1371/journal.pone.0122050
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives Several studies have demonstrated associations of birth weight with metabolic and reproductive abnormalities in adults. The aim of this study was to investigate the birth weight in women with PCOS and its correlation with clinical and biochemical characteristics of the syndrome. Materials and Methods We studied 288 women with PCOS according to the NIH criteria and 166 women with normal cycle and without clinical hyperandrogenism. Birth weight and anthropometric characteristics were recorded, and levels of serum androgens, SHBG, insulin and fasting glucose were measured. Results Birth weight data were available for 243/288 women with PCOS and age- and BMI-matched 101/166 controls. No differences were found (p > 0.05) in birth weight among women with PCOS and normal controls. Birth weight of PCOS women was negatively correlated with DHEAS levels (p = 0.031, r = -0.143) and positively correlated with waist circumference (p < 0.001, r = 0.297) and body mass index (BMI) (p = 0.040, r = 0.132). Birth weight of controls was negatively correlated with SHBG levels (p = 0.021, r = -0.234). Women from both groups were further divided in 6 categories according to birth weight (A. <2.500 gr, B. 2.501-3.000 gr, C. 3.001-3.500 gr, D. 3.501-4.000 gr, E. 4.001-4.500 gr, F. > 4.500 gr). No statistically significant differences were observed in the distribution percentages between PCOS women and controls. (A. 7% vs 7.9%, B. 26.8% vs 20.8%, C. 39.1% vs 48.5%, D. 21.4% vs 20.8%, E. 4.9% vs 2%, F. 0.8% vs 0%), (in all comparisons, p > 0.05). Conclusions Women with PCOS do not differ from controls in birth weight distribution. However, birth weight may contribute to subtypes of the syndrome that are characterized by adrenal hyperandrogenism and central obesity.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] An overview of the physiopathology and various treatment strategies for polycystic ovary syndrome
    Rajabi, Ayda
    Babaie, Soraya
    Sadeghzadeh Oskouei, Behnaz
    Mehdizadeh, Amir
    Farshbaf-Khalili, Azizeh
    REPRODUCTIVE AND DEVELOPMENTAL MEDICINE, 2024, 8 (01) : 50 - 60
  • [32] Quality of Life of Women with Polycystic Ovary Syndrome
    Ligocka, Natalia
    Chmaj-Wierzchowska, Karolina
    Wszolek, Katarzyna
    Wilczak, Maciej
    Tomczyk, Katarzyna
    MEDICINA-LITHUANIA, 2024, 60 (02):
  • [33] Polycystic ovary versus polycystic ovary syndrome - A necessary distinction
    Balen, Adam
    POLYCYSTIC OVARY SYNDROME: CURRENT CONTROVERSIES, FROM THE OVARY TO THE PANCREAS, 2008, : 37 - 49
  • [34] Is prolactin the missing link in adipose tissue dysfunction of polycystic ovary syndrome patients?
    Albu, Alice
    Florea, Suzana
    Fica, Simona
    ENDOCRINE, 2016, 51 (01) : 163 - 173
  • [35] Plasmatic and Intracellular Markers of Oxidative Stress in Normal Weight and Obese Patients with Polycystic Ovary Syndrome
    Di Segni, Chantal
    Silvestrini, Andrea
    Fato, Romana
    Bergamini, Christian
    Guidi, Francesco
    Raimondo, Sebastiano
    Meucci, Elisabetta
    Romualdi, Daniela
    Apa, Rosanna
    Lanzone, Antonio
    Mancini, Antonio
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2017, 125 (08) : 506 - 513
  • [36] The Comparison of Irisin, Subfatin, and Adropin in Normal-Weight and Obese Polycystic Ovary Syndrome Patients
    Majeed, Alabbas Abdulkareem
    Al-Qaisi, Alaa Hussein J.
    Ahmed, Waled Abdo
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2024, 49 (06) : 350 - 358
  • [37] The metabolic syndrome in polycystic ovary syndrome
    Essah, Paulina A.
    Wickham, Edmond P.
    Nestler, John E.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2007, 50 (01) : 205 - 225
  • [38] The metabolic syndrome in polycystic ovary syndrome
    P. A. Essah
    J. E. Nestler
    Journal of Endocrinological Investigation, 2006, 29 : 270 - 280
  • [39] Mitochondrial dysfunction: An emerging link in the pathophysiology of polycystic ovary syndrome
    Shukla, Pallavi
    Mukherjee, Srabani
    MITOCHONDRION, 2020, 52 : 24 - 39
  • [40] Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome
    Day, Felix R.
    Hinds, David A.
    Tung, Joyce Y.
    Stolk, Lisette
    Styrkarsdottir, Unnur
    Saxena, Richa
    Bjonnes, Andrew
    Broer, Linda
    Dunger, David B.
    Halldorsson, Bjarni V.
    Lawlor, Debbie A.
    Laval, Guillaume
    Mathieson, Iain
    McCardle, Wendy L.
    Louwers, Yvonne
    Meun, Cindy
    Ring, Susan
    Scott, Robert A.
    Sulem, Patrick
    Uitterlinden, Andre G.
    Wareham, Nicholas J.
    Thorsteinsdottir, Unnur
    Welt, Corrine
    Stefansson, Kari
    Laven, Joop S. E.
    Ong, Ken K.
    Perry, John R. B.
    NATURE COMMUNICATIONS, 2015, 6